全球猪流感疫苗市场规模（依产品类型、应用、区域范围、预测）

猪流感疫苗市场规模及预测

过去几年，猪流感疫苗市场规模一直快速成长，成长率显着，预计在预测期内（即 2026-2032 年）将大幅成长。

• 猪流感，又称为猪流感，是一种由感染猪的流感病毒引起的呼吸道疾病。该疾病也可传播给人类，导致人类猪流感疫情爆发。
• 全球猪流感市场包括疫苗和治疗剂的开发、製造和分销。
• 猪流感疫苗和治疗方法的应用主要集中在预防和治疗猪和人类的疾病。对猪来说，接种疫苗是为了防止疾病的传播，但这会给农民带来巨大的经济损失。对于人类来说，猪流感疫苗和治疗方法用于预防和治疗这种疾病，这种疾病会导致呼吸道疾病，在严重的情况下，可能导致住院甚至死亡。
• 展望未来，随着人们对该疾病的认识不断提高以及新的、更有效的疫苗和治疗方法的开发，猪流感市场预计将会成长。
• 此外，政府为控制猪流感蔓延和预防未来疫情爆发所做的努力也有望推动市场成长。
• 预计市场也将受益于对动物蛋白产品日益增长的需求，这将推动畜牧业的成长并提高对疾病预防措施的需求。

猪流感疫苗的全球市场动态

影响全球猪流感疫苗市场的关键市场动态：

关键市场驱动因素

• 猪流感患者数量增加：全球猪流感感染人数增加是推动市场成长的主要因素，这反过来又导致对猪流感疫苗的需求增加，从而促进市场的成长。
• 政府推动疫苗接种计画：提高人们对接种猪流感疫苗重要性的认识。全球各国政府为推广疫苗接种计画倡议，推动了市场成长。
• 疫苗生产和分发的进步：随着疫苗製造商现在能够更有效率地生产疫苗并将其分发给更多的人，技术的不断采用将推动市场发展。
• 预防性医疗保健需求不断增加：人们对预防性医疗保健益处的认识不断提高，导致对疫苗（包括猪流感疫苗）的需求增加。
• 医疗保健支出不断增加：人们对疾病预防的日益关注加上全球医疗保健支出的不断增加预计将推动对猪流感疫苗的需求。

主要挑战

• 疫苗地理分布有限：儘管对猪流感疫苗的需求不断增长，但仍有一些地区无法轻易获得这些疫苗，这限制了这些地区的市场潜力。
• 疫苗高成本：猪流感疫苗的成本可能会对部分人口造成障碍，特别是在低收入国家，这可能会限制对疫苗的需求并阻碍市场成长。
• 疫苗有效性有限：猪流感病毒变异迅速，可能降低疫苗的效力。疫苗製造商将面临挑战，需要跟上病毒株的持续演变。
• 严格监管：猪流感疫苗市场受到严格监管，这可能会给製造商在获得核准和遵守监管要求方面带来挑战。
• 疫苗犹豫：人们由于担心副作用和对医疗保健系统缺乏信任等各种原因而犹豫是否接种猪流感疫苗，这可能会限制对疫苗的需求并阻碍市场成长。

主要趋势：

• 疫苗接种担忧加剧：人们对通用感染疾病和猪流感大流行的认识不断提高，推动了猪隻疫苗接种需求的增加。
• 关注牛健康：猪隻生产商意识到猪流感疫苗接种在牛健康和防止生产损失方面具有经济效益。
• 严格的监管措施：监管机构可能会对兽用疫苗实施更严格的品管措施，而政府机构可能会发布有关猪流感疫苗接种的指南，这可能会影响市场成长。

目录

第一章 猪流感疫苗全球市场介绍

• 市场介绍
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球猪流感疫苗市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球猪流感疫苗市场（依产品类型）

• 概述
• 活病毒疫苗
• 灭活疫苗

6. 全球猪流感疫苗市场（依应用）

• 概述
• 产品猪
• 种猪

7. 全球猪流感疫苗市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

8. 全球猪流感疫苗市场竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第九章 公司简介

• Chengdu TECBOND
• Green Cross Veterinary
• Hipra
• MSD Animal Health（Merck）
• Zoetis
• CAHIC
• Merial
• Ceva
• Ringpu Biology
• DHN

第十章 附录

• 相关调查

Swine Influenza Vaccines Market Size And Forecast

Swine Influenza Vaccines Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated to grow significantly during the forecasted period i.e. 2026 to 2032.

• Swine influenza, also known as swine flu, is a respiratory disease caused by the influenza virus that affects pigs. The disease can also be transmitted to humans, leading to outbreaks of human swine influenza.
• The global swine influenza market includes the development, manufacturing, and distribution of vaccines and treatments for the disease.
• The application of swine influenza vaccines and treatments is primarily focused on preventing and treating the disease in pigs and humans. In the case of pigs, vaccination is used to prevent the spread of the disease, which can lead to significant economic losses for farmers. In humans, swine influenza vaccines and treatments are used to prevent and treat the disease, which can cause respiratory illness and, in severe cases, lead to hospitalization or death.
• In terms of future scope, the swine influenza market is expected to grow with increasing awareness about the disease and the development of new and more effective vaccines and treatments.
• Additionally, government initiatives to control the spread of swine influenza and prevent future outbreaks are expected to boost the growth of the market.
• The market is also expected to benefit from the increasing demand for animal protein products, which is driving the growth of the livestock industry and increasing the need for disease prevention measures.

Global Swine Influenza Vaccines Market Dynamics

The key market dynamics that are shaping the global Swine Influenza Vaccines Market include:

Key Market Drivers:

• Increasing Incidence of Swine Flu Cases: The rising prevalence of swine flu infections across the globe is a major factor driving the growth of the market. This has led to an increase in demand for swine flu vaccines, thereby contributing to the market growth.
• Government Initiatives towards Immunization Programs: Growing awareness among people regarding the importance of vaccination against swine influenza. Governments programs around the world are taking initiatives to promote immunization programs, resulted in a boost in the growth of the market.
• Advancements in Vaccine Production and Distribution: Rising adoption of technology will drive the market as vaccine manufacturers are now able to produce vaccines more efficiently and distribute them to a larger population.
• Growing Demand for Preventive Healthcare: Increasing awareness about the benefits of preventive healthcare is leading to a rise in demand for vaccines, including swine flu vaccines.
• Rising Healthcare Expenditure: With the increase in healthcare spending globally, there is a growing focus on disease prevention, which is expected to drive the demand for swine flu vaccines.

Key Challenges:

• Limited Availability of Vaccines in Distinct Regions: Despite the growing demand for swine flu vaccines, there are still some regions where these vaccines are not readily available. This limits the market potential in these areas.
• High Cost of Vaccines: The cost of swine flu vaccines can be a barrier for some individuals, especially in low-income countries. This can limit the demand for vaccines, thereby hindering the growth of the market.
• Limited Efficacy of Vaccines: Swine flu viruses can mutate quickly, which can reduce the efficacy of vaccines. This can be a challenge for vaccine manufacturers to keep up with the evolving strains of the virus.
• Stringent Regulations: The swine flu vaccine market is highly regulated, which can create challenges for manufacturers in terms of obtaining approvals and meeting regulatory requirements.
• Vaccine Hesitancy: Some individuals may be hesitant to receive swine flu vaccines due to various reasons, such as concerns about side effects or a lack of trust in the healthcare system. This can limit the demand for vaccines and hinder the growth of the market.

Key Trends:

• Growing Vaccination Concerns: The rising awareness of zoonotic diseases and the potential swine flu pandemics is driving increased demand for pig vaccination.
• Focus on Herd Well-being: Pig producers are increasingly recognizing the economic benefits of swine flu vaccination for herd health and preventing production losses.
• Stringent Regulatory Measures: Regulatory bodies are implementing stricter quality control measures for animal vaccines, while government agencies may issue guidelines for swine flu vaccination in pigs, potentially influencing market growth.

Global Swine Influenza Vaccines Market Regional Analysis

Here is a more detailed regional analysis of the global Swine Influenza Vaccines Market:

North America:

• The increasing demand for Swine Influenza Vaccines Market is significant in North America because of the region's demand for the product occasionally surges during flu seasons or in reaction to swine flu diseases. In general, the market is growing steadily due to factors like population expansion, immunization campaigns, and public health efforts.
• Witnessing a rise in the number of swine flu influenza cases in recent years. The government in Mexico has been taking various measures to improve the healthcare infrastructure in the country and increase access to vaccines, which has been driving the growth of the market in the region.
• Increasing awareness regarding the importance of vaccination is also expected to drive the market for swine influenza vaccines in North America. As people become more aware of the benefits of vaccination and the risks associated with not vaccinating, they are more likely to seek out vaccines, thereby contributing to the growth of the market.

Europe:

• The European Medicines Agency (EMA) and other regulatory agencies enforce strict guidelines for the approval and production of vaccines, which impacts market entrance obstacles and strategies for product differentiation.
• The main factors driving the demand for swine influenza vaccines include disease outbreaks, government programs encouraging livestock health, and growing swine producer awareness of the advantages of immunization.
• Furthermore, developments in vaccination technology and growing worries about the spread of zoonotic diseases are reflected in market patterns. Product innovation, price strategies, and industry-wide strategic alliances are characteristics of competitive dynamics. Overall, a comprehensive regional study reveals pathways forward and emphasizes the intricate interactions among variables influencing the European Swine Influenza Vaccines Market.

Asia Pacific:

• The Asia Pacific region is an important market for swine influenza vaccines due to the high incidence of the disease in the region. A regional analysis of the market can help identify the key market trends and drivers.
• Increasing demand for vaccine are expected to drive growth due to their large populations and increasing awareness about the importance of vaccination. On the supply side, many leading global players have established their manufacturing facilities in the region, which has helped to increase the availability of vaccines.
• Additionally, there may be cultural barriers to vaccine adoption in some regions, which will need to be addressed through targeted marketing and education campaigns.

Global Swine Influenza Vaccines Market: Segmentation Analysis

The Global Swine Influenza Vaccines Market is segmented on the basis of Product Type, Application, And Geography.

Swine Influenza Vaccines Market, By Product Type

• Live Vaccine
• Killed Vaccine

Based on Product Type, The market is segmented into Live Vaccine and Killed Vaccine. The Live vaccine is dominated throughout the forecast period. Due to Live vaccines exhibit superior efficacy in conferring cross-protection against emerging strains and variants, offering a strategic advantage in combating evolving disease threats within the swine industry. Despite concerns regarding potential reversion to virulence and strict storage and handling requirements, advancements in vaccine technology and stringent quality control measures have significantly mitigated these risks, bolstering confidence among stakeholders.

Swine Influenza Vaccines Market, By Application

• Commodity Pig
• Breeding Pig

Based on Application, The market is segmented into Commodity Pig and Breeding Pig. The commodity pig is dominate the market often raised for meat production purposes, represent a significant portion of the swine population in Europe. Given the large-scale nature of commodity pig production and the emphasis on maximizing efficiency and productivity, disease prevention measures, including vaccination, are crucial for maintaining herd health and minimizing economic losses associated with disease outbreaks. Swine influenza vaccines play a vital role in protecting commodity pig herds from respiratory diseases, ensuring optimal growth rates and meat quality.

Key Players

The "Global Swine Influenza Vaccines Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Chengdu TECBOND,Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Merial, Ceva, Ringpu Biology, and DHN.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

• Swine Influenza Vaccines Market: Recent Developments
• In August 2023, Boehringer ingelheim introduced new influenza vaccine for swine. They developed and sold by Boehringer Ingelheim, Ingelvac Provenza is the first live attenuated influenza vaccine for growing pigs and provides protection against the threat of influenza virus strains H1N2 and H3N21.
• In June, 2023, Husker scientist has developed a robust vaccine against a strain of swine influenza. Framed by a model of nucleic acid proteins. They developed more efficient and long-lasting vaccination strategies in vulnerable pig population.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SWINE INFLUENZA VACCINES MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL SWINE INFLUENZA VACCINES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL SWINE INFLUENZA VACCINES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Live Vaccines
• 5.3 Killed Vaccines

6 GLOBAL SWINE INFLUENZA VACCINES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Commodity Pig
• 6.3 Breeding Pig

7 GLOBAL SWINE INFLUENZA VACCINES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL SWINE INFLUENZA VACCINES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Chengdu TECBOND
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Green Cross Veterinary
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Hipra
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 MSD Animal Health (Merck)
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Zoetis
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 CAHIC
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Merial
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Ceva
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Ringpu Biology
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 DHN
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research